General Manager Business Development, Celaid Therapeutics Inc.

Ph.D. from University of Arizona. After years of research experience at Cornell University, led a team to establish cell/gene therapy safety assessment department at SNBL, Ltd., the largest pre-clinical CRO in Japan.